Cargando…
Significant partial response of metastatic intra-abdominal and pelvic round cell liposarcoma to a small-molecule VEGFR-2 tyrosine kinase inhibitor apatinib: A case report
INTRODUCTION: Myxoid/round cell liposarcoma is the second most common subtype of liposarcoma. Chemotherapy and radiotherapy have a limited efficacy for treating advanced myxoid/round cell liposarcoma, with relatively serious side effects. CASE PRESENTATION: We herein present a 68-year-old Chinese wo...
Autores principales: | Dong, Min, Bi, Jingwang, Liu, Xiaohong, Wang, Baocheng, Wang, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979796/ https://www.ncbi.nlm.nih.gov/pubmed/27495042 http://dx.doi.org/10.1097/MD.0000000000004368 |
Ejemplares similares
-
Effective apatinib treatment of pleomorphic liposarcoma: A case report
por: Yan, Peng, et al.
Publicado: (2017) -
Single-center experience with intra-abdominal liposarcoma: Optimal minimum duration for postoperative remnant tumor screening
por: Rhu, Jinsoo, et al.
Publicado: (2017) -
Myxoid Liposarcoma in the Abdominal Wall: A Case Report
por: Fan, Zhe, et al.
Publicado: (2014) -
Apatinib as an optional treatment in metastatic colorectal cancer
por: Li, Aiyi, et al.
Publicado: (2019) -
Local microwave ablation with continued EGFR tyrosine kinase inhibitor as a treatment strategy in advanced non-small cell lung cancers that developed extra-central nervous system oligoprogressive disease during EGFR tyrosine kinase inhibitor treatment: A pilot study
por: Ni, Yang, et al.
Publicado: (2016)